Clinical Trials Browser

Phase 2 × INDUSTRY × tocilizumab × Clear all

NCT05207670 2026-03-05

MorningSun

Phase 2 Active not recruiting

Lymphoma, Non-Hodgkin

NCT01242488 2024-07-17

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Phase 2 Completed

Arthritis, Rheumatoid